Fruquintinib Capsules

DRUG2 trials

Sponsors

Fudan University, Nanjing Leads Biolabs Co.,Ltd

Conditions

Metastatic Colorectal CarcinomaPlatinum Resistant Ovarian Cancer

Phase 1

A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma

Not yet recruitingNCT07791758

Nanjing Leads Biolabs Co.,LtdMetastatic Colorectal Carcinoma

Start: 2026-09-04End: 2030-09-04Target: 369Updated: 2026-09-02

Phase 2

Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer

Not yet recruitingNCT06973421

Fudan UniversityPlatinum Resistant Ovarian Cancer

Start: 2025-07-01End: 2028-06-30Target: 35Updated: 2025-05-15

Related Papers

Phase II study of utidelone plus fruquintinib for the treatment of platinum-resistant recurrent ovarian cancer (FRUTD trial).

Journal of Clinical Oncology2026-05-27